Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports

Innovative apps to foster the growth of Autogenous Vaccine For Aquaculture Market

The global Autogenous Vaccine For Aquaculture Market is bound to witness stupendous growth In Upcoming Years. One of the upcoming trends is that of offbeat thinking being put into practice. Also, the demand regarding automation would rise by over 10% in the subsequent decade. Moreover, with user-generated content creating ripples, the market is bound to blur the gap between one-way communication and constructive feedback to adhere to the end-users mindshare.

Fish is a widely consumed food across the world. In 2019, 177.8 million metric tons of fish were produced globally. In spite of such huge production in aquaculture, bacterial disease is a major issue, and is causing multibillion-dollar losses annually. In developing countries, fish diseases often spread quickly between small-scale aquaculture farms. Rising prevalence of infectious diseases such as bacterial diseases, viral diseases, and parasitic and fungal diseases amongst fish species remains a global issue for fish farmers.

Autogenous vaccines have been playing a vital role in bacterial disease control in aquaculture. This is the most effective method for preventing a wide range of bacterial and viral diseases. Autogenous vaccines are widely accepted by aquaculture farming companies during emergency outbreaks, due to very few commercial vaccines being available for specific aquaculture-related diseases.

According to the latest report published by Persistence Market Research, the global autogenous vaccine for the aquaculture market was valued at US$ 11 Mn in 2020, and is expected to witness a CAGR of 5.5% during the forecast period (2020 – 2030).

Get Sample Copy of Report @

Companies covered in Autogenous Vaccine For Aquaculture Market Report

  • IDT Biologika GmbH (Ridgeway Biologicals Ltd)
  • Ceva Biovac
  • Zoetis (PHARMAQAS)
  • Vaxxinova
  • Barramundi Asia Pte Ltd.(UVAXX Asia)
  • AniCon Labor GmbH
  • sanphar (ipeve)
  • Kennebec River Biosciences

Get A Customized Scope To Match Your Need Ask An Expert –

Get To Know Methodology of Report @

 Key Takeaways from Autogenous Vaccine for Aquaculture Market Study

“Rise in prevalence of infectious diseases and demand for autogenous vaccines for preventive treatment will boost sales of autogenous vaccines for aquaculture over the coming years,” says an analyst at Persistence Market Research.

Access Full Report @

Collaborations & Acquisitions Key Strategy amongst Market Players

Leading players in the autogenous vaccine for aquaculture market are strengthening their product portfolios through acquisitions and expanding their regional presence.

  • For instance, in July 2019, Ceva Santé Animale announced the acquisition of IDT’s veterinary pharmaceutical and R&D activities.
  • In April 2018, Pharmaq announced the production of fish vaccines at a development center in Suzhou, China.
  • In November 2016, Ceva announced the acquisition of Hertape Saude Animale Ltda. and Inova Biotecnologia Saude Animale Ltda., two leading Brazilian veterinary biopharmaceutical companies.
  • Various players in the autogenous vaccine for aquaculture market are focusing on growth strategies such as collaboration and agreement licences.
  • In December 2020, HIPRA announced its collaboration with IBM to digitize the animal vaccination process.
  • In April 2019, MARINNOVAC collaborated with CZVACCINES S.A and established AQUATRECK ANIMAL HEALTH S.L, an aquaculture pharmaceutical company.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the autogenous vaccine for aquaculture market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2020, on the basis of fish species (salmon, tilapia, bream, Labris Bergylta, Cyprinus Carpio, Sea Bass, Trout, and Cyclopterus Lumpus), pathogen type (bacteria and virus), and end user (fish farming companies and aquatic research institutes), across seven key regions of the world.

About us: Persistence Market Research

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –


Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts